JOURNAL OF PSYCHOPHARMACOLOGY

The Journal of Psychopharmacology (ISSN 0269-8811) is a distinguished monthly peer-reviewed publication based in the United Kingdom and issued by SAGE, serving as a key venue for advancing knowledge in the field of psychopharmacology. As an SCI-indexed journal, it maintains a solid academic standing, typically ranking in the third or fourth quartile of the Chinese Academy of Sciences journal classification for medical and pharmacological sciences, reflecting its consistent impact factor within the discipline. The journal publishes high-quality original research articles, comprehensive reviews, and brief communications that explore both the fundamental mechanisms and clinical applications of psychotropic agents, with a particular focus on the pharmacological management of neuropsychiatric disorders, drug action mechanisms, clinical trial outcomes, and the management of adverse effects. While the journal adheres to rigorous editorial standards that prioritize methodological robustness and novelty, it operates as a subscription-based publication rather than an open-access platform, which may present access barriers for some readers. Consequently, authors are advised to ensure their submissions demonstrate significant scientific innovation and strict adherence to methodological rigor to navigate the competitive review process effectively.